SCHEMBL3287969

SCHEMBL3287969

OSc1ccco1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2209772 0.77 TP53 (0.41)
SCHEMBL2212333 0.77 TP53 (0.41)
SCHEMBL15049289 0.72
SCHEMBL5529361 0.72
SCHEMBL7326886 0.72
SCHEMBL2270636 0.72
SCHEMBL3084124 0.70
SCHEMBL1261902 0.70 ALDH1A1 (0.36)
SCHEMBL20378696 0.70 TP53 (0.36)
Hydrochloric Acid SCHEMBL28543687 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7692030-B2 Conjugates of artemisinin-related endoperoxides and hydrazone derivatives for the treatment of cancer UNIVERSITY OF WASHINGTON (US) 2010-04-06 US disclosed
US-20080103192-A1 CONJUGATES OF ARTEMISININ-RELATED ENDOPEROXIDES AND HYDRAZONE DERIVATIVES FOR THE TREATMENT OF CANCER WASHINGTON, UNIVERSITY OF (US) 2008-05-01 US disclosed
WO-2008046109-A2 CONJUGATES OF ARTEMISININ-RELATED ENDOPEROXIDES AND HYDRAZONE DERIVATIVES FOR THE TREATMENT OF CANCER UNIVERSITY OF WASHINGTON (US) 2008-04-17 WO disclosed